ArticleJACC. Case reports2026
Progressive Conduction Disease on Serial ECGs Revealing Immune Checkpoint Inhibitor-Associated Myocarditis and Myositis.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundImmune checkpoint inhibitors are effective treatments for cancer but also carry cardiovascular toxicity risks. CASE SUMMARY: An 83-year-old male receiving cemiplimab for advanced squamous and basal cell carcinoma presented with severe back pain. One week earlier, electrocardiogram (ECG) demonstrated atrial flutter with new right bundle branch block, slowed atrial activity, and possible complete heart block with a ventricular rate of 48 beats/min, alongside rising liver enzyme abnormalities. On admission, ECG demonstrated complete heart block. Troponin and creatine kinase were elevated. He developed Society for Cardiovascular Angiography and Interventions (SCAI) Stage C cardiogenic shock treated with transvenous pacing. Progressive ophthalmoplegia, proximal weakness, and respiratory decline followed. He received high-dose methylprednisolone, intravenous immunoglobulin, and permanent pacemaker implantation. Muscle biopsy confirmed immune-mediated necrotizing inflammatory myopathy. DISCUSSION: Serial ECG evolution suggested early immune checkpoint inhibitor myocarditis. Despite rapid immunosuppression, his disease was steroid-refractory and fatal. TAKE-HOME MESSAGES: Progressive conduction abnormalities on electrocardiogram may be an early manifestation of immune-checkpoint inhibitor myocarditis, before troponin elevation. Baseline and surveillance electrocardiograms can detect progressive conduction abnormalities as manifestations of early immune-checkpoint inhibitor toxicity and guide emerging mechanism-matched immunosuppression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.